---
layout: default
title: Calcium Carbonate
parent: 僅模型預測 (L5)
nav_order: 90
evidence_level: L5
indication_count: 0
---

# Calcium Carbonate
{: .fs-9 }

證據等級: **L5** | 預測適應症: **0** 個
{: .fs-6 .fw-300 }

---

## 目錄
{: .no_toc .text-delta }

1. TOC
{:toc}

---

<div id="pharmacist">

## 藥師評估報告

</div>

# Calcium Carbonate: Repurposing Evaluation Pending Data Remediation

## One-Sentence Summary

Calcium Carbonate (DrugBank ID: DB06724) is a well-characterised inorganic compound with broad pharmaceutical use, though no approved indications were retrieved from the current regulatory dataset. The TxGNN model did not generate any repurposing predictions for this compound in the current analysis cycle, and two blocking or high-severity data gaps remain unresolved. A full repurposing evaluation cannot be completed until these gaps are remediated.

## Quick Overview

| Item | Content |
|------|---------|
| Original Indication | Not available in current dataset |
| Predicted New Indication | No predictions generated in current cycle |
| TxGNN Prediction Score | N/A |
| Evidence Level | N/A |
| South Africa Market Status | Not marketed |
| Number of SAHPRA Registrations | 0 |
| Recommended Decision | Hold |

## Safety Considerations

Please refer to the SAHPRA-approved Professional Information (PI) for safety information. Report adverse drug reactions to SAHPRA.

## Conclusion and Next Steps

**Decision: Hold**

**Rationale:**
The TxGNN pipeline returned no repurposing predictions for Calcium Carbonate in this cycle, and two unresolved data gaps — a blocking gap in safety/PI data and a high-severity gap in mechanism of action — prevent meaningful safety or mechanistic evaluation. Additionally, no SAHPRA registrations were identified in the dataset, making a South African market context assessment impossible without further investigation.

**To proceed, the following is needed:**

- **Remediate DG001 (Blocking):** Obtain the SAHPRA-approved Professional Information (PI) by downloading and parsing the official PI PDF from the SAHPRA website; this is required before any safety screening can proceed
- **Remediate DG002 (High):** Query the DrugBank API for DB06724 to retrieve mechanism of action data; this is required to support mechanistic plausibility analysis
- **Investigate absent predictions:** Verify that DB06724 is correctly represented as a node in the TxGNN knowledge graph and that drug–disease edges are present; if the node is missing or disconnected, re-run the KG mapping and prediction pipeline
- **Confirm SAHPRA registration status:** Calcium Carbonate is a widely used compound — confirm whether South African registrations exist under a different DrugBank entry, product name, or combination product, and update `total_licenses` accordingly
- **Re-run full pipeline** after all blocking and high-severity data gaps are resolved to generate a complete Evidence Pack (v5+)

---

> ⚠️ **Disclaimer:** This report is intended for research reference only and does not constitute medical advice. All drug repurposing candidates require clinical validation before any therapeutic application. Please report any adverse drug reactions to SAHPRA.
## Disclaimer

This content is for research purposes only and does not constitute medical advice.
Clinical validation is required before any clinical application.

---

